Chlamydia Treatment Guidelines

Introduction

• Chlamydia treatment guidelines are established by the Centers for Disease Control and Prevention (CDC) and other health organizations to provide effective treatment and management of the disease 1, 2, 3

Treatment Regimens

• The CDC recommends doxycycline 100 mg orally twice daily for 7 days, with an efficacy of 95.5% for urogenital infections and 96.9% for rectal infections, as a first-line treatment option 4, 3, 2, 5
• Azithromycin 1g orally in a single dose is recommended as an alternative treatment option, with higher efficacy compared to doxycycline for M. genitalium and as an alternative treatment option when adherence is a concern, with a strength of evidence rated as high 4, 3, 2, 5
• Erythromycin base 500 mg orally four times a day for 7 days and Amoxicillin 500 mg orally three times a day for 7-10 days are recommended as alternative regimens for patients who cannot use azithromycin 2, 3
• The following table summarizes the efficacy of different medications for chlamydia treatment:

• Doxycycline and ofloxacin are contraindicated during pregnancy, according to the CDC 2, 3
• Azithromycin is preferred for chlamydia treatment in pregnant women, as per CDC guidelines 1, 2

Partner Management

• All sexual partners from the previous 60 days should be evaluated, tested, and treated, as recommended by the CDC 1, 4, 2
• If no sexual contact occurred within 60 days, the most recent partner should be treated, according to the CDC 2
• Patients and partners should abstain from sexual intercourse until 7 days after single-dose therapy or until completion of a 7-day regimen, as advised by the CDC 1, 6, 5, 2

Patient Management

• Patients should be instructed to abstain from sexual intercourse for 7 days after single-dose therapy (azithromycin) or until completion of a 7-day regimen, as recommended by the CDC 2
• Patients should be instructed to abstain from sexual intercourse until all partners have been treated, according to the CDC 2
• Patients with persistent symptoms after treatment should be evaluated by culture for N. gonorrhoeae, and any isolates should be tested for antimicrobial susceptibility, as recommended by the CDC 4, 1, 3
• The CDC emphasizes the importance of taking all medication regardless of symptoms, partner notification and treatment, and abstaining from sexual activity until treatment completion, as stated in their 1991 report 7

Follow-up

• For non-pregnant patients, no test of cure is needed if treated with doxycycline or azithromycin unless symptoms persist, as recommended by the CDC 2
• For pregnant patients, a test of cure is recommended 3 weeks after completing treatment, according to the CDC 3, 4, 8, 6
• All patients should be considered for retesting approximately 3 months after treatment due to high risk of reinfection (up to 39% in some studies), as recommended by the CDC 1, 6, 5, 2
• The CDC recommends that all patients diagnosed with gonorrhea should be retested 3 months after treatment, regardless of whether they believe their partners have been treated 4, 8

Special Considerations

• Pregnant women require special consideration, including mandatory test of cure for chlamydia, and should be retested in the third trimester if diagnosed in the first trimester, according to the American College of Physicians and CDC guidelines 4, 8, 6
• The same treatment regimens apply to HIV-positive patients as to HIV-negative patients, according to CDC guidelines 1
• Untreated trichomoniasis can lead to increased risk of HIV acquisition, pelvic inflammatory disease, and complications in women, as stated by the CDC 3
• The CDC recommends Metronidazole (Flagyl) as the treatment for Trichomonas vaginalis, based on recommendations from 1993 and 1998 3, 2